Dr. Stephen Ferguson is an internationally recognized leader in the Molecular Pharmacology of G protein coupled receptors (GPCRs) whose ground-breaking research contributions have tremendously advanced our current understanding of GPCR trafficking and physiology. GPCRs account for the majority of drug targets and Dr. Ferguson's research focuses on understanding how GPCR trafficking and altered pharmacological regulation, contribute to disease progression and treatment in hypertension, mental health and neurodegenerative disease such as Alzheimer's and Huntington's disease. He is the founder of the Annual Great Lakes GPCR retreat that provides trainees with networking opportunities and showcases the excellence of Canadian science.